代表法国药理学学会和欧洲药理学学会联合会出版的EPHAR基础与临床药理学报告描述了与药物治疗相关的基础和临床研究的重要和新进展。原始文章简短的交流和评论发表在实验和临床药理学的各个方面,包括:抗菌抗病毒药物自主药理学心血管药理学内分泌药理学炎症免疫药理学肝脏与G-I道药理学代谢药代动力学与药物基因学神经药理学肿瘤学儿科药理学与发育药理学药理学流行病学与临床试验药物基因学与基因治疗肺药理学肾脏药理学血栓与止血临床研究包括临床研究与临床试验可涵盖药物动力学、药效学、药效学、药效学、警惕性、药理学、流行病学、药物基因组学和药物经济学等学科。也欢迎来自生理学和分子生物学等领域的基础研究文章,有助于理解药物治疗。
Published on behalf of the Société Fran?aise de Pharmacologie and of the Federation of the European Pharmacological Societies EPHAR Fundamental & Clinical Pharmacology publishes reports describing important and novel developments in fundamental as well as clinical research relevant to drug therapy. Original articles short communications and reviews are published on all aspects of experimental and clinical pharmacology including: Antimicrobial Antiviral Agents Autonomic Pharmacology Cardiovascular Pharmacology Endocrinopharmacology Inflammation & Immunopharmacology Liver & G-I Tract Pharmacology Metabolism Pharmacokinetics & Pharmacogenetics Neuropharmacology Oncology Pediatric Pharmacology & Development Pharmacoeconomics Pharmacoepidemiology & Clinical Trials Pharmacogenetics & Gene Therapy Pulmonary Pharmacology Renal Pharmacology Thrombosis & Hemostasis Clinical research including clinical studies and clinical trials may cover disciplines such as pharmacokinetics pharmacodynamics pharmacovigilance pharmaco-epidemiology pharmaco-genomics and pharmaco-economics. Basic research articles from fields such as physiology and molecular biology which contribute to an understanding of drug therapy are also welcomed.
SCI热门推荐期刊 >
SCI常见问题 >
职称论文常见问题 >
EI常见问题 >